Streetbeat News

Stock Prices

SNGX

Soligenix shares surged following the FDA's grant of orphan drug designation to MarVax's active ingredient for MARV infection prevention and post-exposure prophylaxis. This designation could potentially accelerate MarVax's development and approval process, highlighting Soligenix's commitment to addressing rare diseases.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:37 am

STZ

Argus Research analyst John Staszak has upgraded Constellation Brands (NYSE:STZ) from Hold to Buy and set a price target of $306.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:37 am

PVH

Wedbush analyst Tom Nikic upgraded PVH Corp (NYSE:PVH) from Neutral to Outperform and increased the price target from $113 to $128, indicating a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:35 am

GS

Goldman Sachs shares are trading higher following the announcement of their Q1 earnings, which surpassed analysts' expectations in both EPS and revenues.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:34 am

SNPO

Snap One Holdings is set to be acquired by Resideo Technologies, leading to an increase in Snap One's share prices.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:30 am

TELA

TELA Bio has announced the U.S. commercial launch of OviTex IHR, a product designed for use in laparoscopic and robotic-assisted inguinal hernia repair. This launch marks a significant step for TELA Bio in expanding its product offerings in the surgical repair market, potentially increasing its market share and revenue from sales of OviTex IHR.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:28 am

AAPL

CRM

GS

MTB

QQQ

SCHW

SPY

TSLA

U.S. stocks are poised for a rebound despite geopolitical tensions, with futures indicating a positive open. The SPDR S&P 500 ETF Trust and Invesco QQQ ETF saw premarket gains. Analysts highlight a buying opportunity in tech stocks, expecting a strong earnings season to drive growth. Tesla, Apple, and Salesforce faced premarket declines due to various concerns, while Goldman Sachs, M&T Bank, and Charles Schwab are set to report earnings. Economic data releases and Fed speakers are also in focus.

Portfolio Pulse from Shanthi Rexaline

April 15, 2024 | 11:27 am

MRNS

Trading for MRNS was halted but has now resumed as of 7:25:00 AM ET, following an update on quotation resumption times.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:25 am

NMRA

Neumora Therapeutics' stock is trading lower following the FDA's decision to place a clinical hold on its Phase 1 NMRA-266 study.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:24 am

MVPA

PRYMF

WIRE

ZIG

Encore Wire Corporation (NASDAQ:WIRE) has agreed to be acquired by Prysmian S.P.A. (OTC:PRYMF) for $290.00 per share in cash, a premium of around 20% to the 30-day VWAP and 29% to the 90-day VWAP as of April 12, 2024. The deal, valued at approximately €3.9 billion, represents multiples of 8.2x and 6.3x EV/2023A EBITDA, with and without run-rate synergies, respectively. The acquisition, expected to close in the second half of 2024, is anticipated to generate €140 million in EBITDA synergies within four years. Investors can gain exposure to Encore Wire through ETFs like MVPA and ZIG.

Portfolio Pulse from Lekha Gupta

April 15, 2024 | 11:22 am